ArticleJournal of gastrointestinal oncology2025

Progress in precision therapies for advanced cholangiocarcinoma: inhibitors of FGFR1-3.

Jonathan WadsleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.